The ROE as of December 2025 (TTM) for Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) is 0.02%

According to Shandong Buchang Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 0.02%. This represents a change of -121.73% compared to the average of -0.07% of the last 4 quarters.

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) Historical ROE (quarterly & annually)

How has 603858.SS ROE performed in the past?

The mean historical ROE of Shandong Buchang Pharmaceuticals Co., Ltd. over the last ten years is 11.14%. The current 0.02% ROE has changed -99.86% with respect to the historical average. Over the past ten years (40 quarters), 603858.SS's ROE was at its highest in in the December 2015 quarter at 9.01%. The ROE was at its lowest in in the December 2022 quarter at -22.62%.

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Shandong Buchang Pharmaceuticals Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) Average ROE

How has 603858.SS ROE performed in the past?

The current ROE of Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) ROE vs. Peers

How is 603858.SS’s ROE compared to its peers?

Shandong Buchang Pharmaceuticals Co., Ltd.’s ROE is less than Beijing Aosaikang Pharmaceutical Co., Ltd. (8.18%), less than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (8.31%), less than Apeloa Pharmaceutical Co.,Ltd (12.78%), greater than Guangdong Zhongsheng Pharmaceutical Co., Ltd. (-4.97%), less than Walvax Biotechnology Co., Ltd. (0.52%), greater than Fujian Cosunter Pharmaceutical Co., Ltd. (-57.69%), greater than Shenzhen Kangtai Biological Products Co., Ltd. (-1.04%), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (3.43%), greater than Hybio Pharmaceutical Co., Ltd. (-10.38%), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (14.47%),

Build a custom stock screener for Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shandong Buchang Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shandong Buchang Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.